BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34601164)

  • 1. A novel μ-oxo-diruthenium(III,III)-ibuprofen-(4-aminopyridine) chloride derived from the diruthenium(II,III)-ibuprofen paddlewheel metallodrug shows anticancer properties.
    Alves SR; Santos RLSR; Fornaciari B; Colquhoun A; de Oliveira Silva D
    J Inorg Biochem; 2021 Dec; 225():111596. PubMed ID: 34601164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axially-modified paddlewheel diruthenium(II,III)-ibuprofenato metallodrugs and the influence of the structural modification on U87MG and A172 human glioma cell proliferation, apoptosis, mitosis and migration.
    Hanif-Ur-Rehman ; Freitas TE; Gomes RN; Colquhoun A; de Oliveira Silva D
    J Inorg Biochem; 2016 Dec; 165():181-191. PubMed ID: 28340940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diruthenium(ii,iii) metallodrugs of ibuprofen and naproxen encapsulated in intravenously injectable polymer-lipid nanoparticles exhibit enhanced activity against breast and prostate cancer cells.
    Alves Rico SR; Abbasi AZ; Ribeiro G; Ahmed T; Wu XY; de Oliveira Silva D
    Nanoscale; 2017 Aug; 9(30):10701-10714. PubMed ID: 28678269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of terpolymer-lipid encapsulated diruthenium(II,III)-anti-inflammatory metallodrug nanoparticles to enhance activity against glioblastoma cancer cells.
    Alves SR; Colquhoun A; Wu XY; de Oliveira Silva D
    J Inorg Biochem; 2020 Apr; 205():110984. PubMed ID: 31927403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel binuclear μ-oxo diruthenium complexes combined with ibuprofen and ketoprofen: Interaction with relevant target biomolecules and anti-allergic potential.
    Seuanes GC; Moreira MB; Petta T; de Moraes Del Lama MPF; de Moraes LAB; de Oliveira ARM; Naal RMZG; Nikolaou S
    J Inorg Biochem; 2015 Dec; 153():178-185. PubMed ID: 26298864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ru
    Lenis-Rojas OA; Robalo MP; Tomaz AI; Carvalho A; Fernandes AR; Marques F; Folgueira M; Yáñez J; Vázquez-García D; López Torres M; Fernández A; Fernández JJ
    Inorg Chem; 2018 Nov; 57(21):13150-13166. PubMed ID: 30339386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving Cytotoxicity against Breast Cancer Cells by Using Mixed-Ligand Ruthenium(II) Complexes of 2,2'-Bipyridine, Amino Acid, and Nitric Oxide Derivatives as Potential Anticancer Agents.
    Gaspari APS; da Silva RS; Carneiro ZA; de Carvalho MR; Carvalho I; Pernomian L; Ferreira LP; Ramos LCB; de Souza GA; Formiga ALB
    Anticancer Agents Med Chem; 2021; 21(12):1602-1611. PubMed ID: 33081686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic and mechanistic studies on reactions of diruthenium(II,III) with biologically relevant reducing agents.
    Santos RL; van Eldik R; de Oliveira Silva D
    Dalton Trans; 2013 Dec; 42(48):16796-805. PubMed ID: 24081178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of Reactions of Dirhodium and Diruthenium Paddlewheel Tetraacetate Complexes with Nucleophilic Protein Sites: Computational Insights.
    Tolbatov I; Marrone A
    Inorg Chem; 2022 Oct; 61(41):16421-16429. PubMed ID: 36194651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-Assembly of Discrete Ru
    Ajibola Adeyemo A; Shettar A; Bhat IA; Kondaiah P; Mukherjee PS
    Inorg Chem; 2017 Jan; 56(1):608-617. PubMed ID: 27997153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Half-Sandwich Ru(
    Lenis-Rojas OA; Robalo MP; Tomaz AI; Fernandes AR; Roma-Rodrigues C; Teixeira RG; Marques F; Folgueira M; Yáñez J; Gonzalez AA; Salamini-Montemurri M; Pech-Puch D; Vázquez-García D; Torres ML; Fernández A; Fernández JJ
    Inorg Chem; 2021 Mar; 60(5):2914-2930. PubMed ID: 33570919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Variations on the Theme of Gold(III) C
    Carboni S; Zucca A; Stoccoro S; Maiore L; Arca M; Ortu F; Artner C; Keppler BK; Meier-Menches SM; Casini A; Cinellu MA
    Inorg Chem; 2018 Dec; 57(23):14852-14865. PubMed ID: 30457328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor pentamethylcyclopentadienyl rhodium complexes of maltol and allomaltol: synthesis, solution speciation and bioactivity.
    Dömötör O; Aicher S; Schmidlehner M; Novak MS; Roller A; Jakupec MA; Kandioller W; Hartinger CG; Keppler BK; Enyedy ÉA
    J Inorg Biochem; 2014 May; 134():57-65. PubMed ID: 24556426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and antitumor mechanism investigation of iridium(III) complexes conjugated with ibuprofen.
    Chen SQ; Lu XY; Zhu LY; Zhu H; Li RT; Ye RR
    J Inorg Biochem; 2024 Aug; 257():112596. PubMed ID: 38759264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drastic Tuning of the Electronic Structures of Diruthenium Aryl Complexes by Isoelectronic Axial Ligands.
    Raghavan A; Yuan F; Ren T
    Inorg Chem; 2020 Jul; 59(13):8663-8666. PubMed ID: 32568533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coordination-driven self-assembly of ruthenium(ii) architectures: synthesis, characterization and cytotoxicity studies.
    Adeyemo AA; Shettar A; Bhat IA; Kondaiah P; Mukherjee PS
    Dalton Trans; 2018 Jun; 47(25):8466-8475. PubMed ID: 29901668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro and in-vivo evaluation of the anticancer activity of diruthenium-2, a new trithiolato arene ruthenium complex [(η6-p-MeC6H4Pri)2Ru2(μ-S-p-C6H4OH)3]Cl.
    Muthná D; Tomšík P; Havelek R; Köhlerová R; Kasilingam V; Čermáková E; Stíbal D; Řezáčová M; Süss-Fink G
    Anticancer Drugs; 2016 Aug; 27(7):643-50. PubMed ID: 27187018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyphenation of lipophilic ruthenium(II)-diphosphine core with 5-fluorouracil: an effective metallodrug against glioblastoma brain cancer cells.
    Saha A; Mondal I; Kumari A; Sonkar AK; Mishra R; Kulshreshtha R; Patra AK
    Dalton Trans; 2024 Jan; 53(4):1551-1567. PubMed ID: 38164612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paddlewheel-type diruthenium(iii,iii) tetrakis(2-aminopyridinate) complexes with NIR absorption features: combined experimental and theoretical study.
    Kataoka Y; Imasaki N; Arakawa K; Yano N; Sakiyama H; Sugimori T; Mitsumi M; Handa M
    Dalton Trans; 2019 Sep; 48(33):12421-12429. PubMed ID: 31265027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of the Microtubule Network and Inhibition of VEGFR2 Phosphorylation by Cytotoxic
    Acharya S; Maji M; Chakraborty MP; Bhattacharya I; Das R; Gupta A; Mukherjee A
    Inorg Chem; 2021 Mar; 60(5):3418-3430. PubMed ID: 33554592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.